The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

PITTSBURGH, Dec. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic ...

Strides Pharma Global, Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg and 400 mg from the Food and Drug Administration. The product is the generic of Upjohn’s Celebrex. The ...

The company "has received Abbreviated New Drug Application (ANDA) final approval for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg," Jubilant Life Sciences said in a BSE filing. This is third ...

The US Food and Drug Administration (FDA) today approved the first generic versions of the anti-inflammatory drug celecoxib (Celebrex, Pfizer) in the wake of legal wrangling between the brand-name ...

Mumbai, Baltimore, December 11, 2014: Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the authorized generic for G.D.

Celebrex 200mg celecoxib — generic over the internet. For safe and effective use of this medicine, do not take more of it, do not take it more often, and do not take it for a longer time than your ...

Strides Pharma has said that its step-down wholly owned subsidiary, Strides Pharma Global Pte., Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg, and 400 mg, from the United ...

Bengaluru-based Strides Pharma Science Limited (Strides) on Wednesday said that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for ...

Zydus Lifesciences Limited, a pharma firm has received final approval from the United States Food and Drug Administration (USFDA) for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, the ...

Shares of Unichem Laboratories were trading at ₹280.55 per scrip on BSE, up 1.04% from its previous close. Drug firm Unichem Laboratories on Wednesday said it has received approval from the US health ...